Microba Life Sciences Limited (ASX:MAP)
0.1550
-0.0200 (-11.43%)
May 14, 2025, 4:10 PM AEST
Revenue by Product
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
---|---|---|---|---|---|
Testing Services & Supplements | 12.09M |
Log In |
Log In |
Log In |
Log In |
Testing Services & Supplements Growth | 123.06% |
Log In |
Log In |
Log In |
Log In |
Research and Other Platform Services | - |
Log In |
Log In |
Log In |
Log In |
Microbiome Testing Services | - |
Log In |
Log In |
Log In |
Log In |
Goods | - |
Log In |
Log In |
Log In |
Log In |
Microbiome | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
---|---|---|---|---|---|
United Kingdom | 4.53M |
Log In |
Log In |
Log In |
Log In |
United Kingdom Growth | 366514.48% |
Log In |
Log In |
Log In |
Log In |
Australia | 4.20M |
Log In |
Log In |
Log In |
Log In |
Australia Growth | 32.98% |
Log In |
Log In |
Log In |
Log In |
Europe | 1.77M |
Log In |
Log In |
Log In |
Log In |
Europe Growth | 63.67% |
Log In |
Log In |
Log In |
Log In |
United Arab Emirates | 662.34K |
Log In |
Log In |
Log In |
Log In |
United Arab Emirates Growth | 45.03% |
Log In |
Log In |
Log In |
Log In |
United States | 602.86K |
Log In |
Log In |
Log In |
Log In |
United States Growth | 8.73% |
Log In |
Log In |
Log In |
Log In |
Ireland | 168.85K |
Log In |
Log In |
Log In |
Log In |
New Zealand | 127.03K |
Log In |
Log In |
Log In |
Log In |
New Zealand Growth | -22.34% |
Log In |
Log In |
Log In |
Log In |
Asia | 22.05K |
Log In |
Log In |
Log In |
Log In |
Singapore | - |
Log In |
Log In |
Log In |
Log In |